News & Events
Ivantis Completes Enrollment in Pivotal HYDRUS IV Glaucoma Study of the Hydrus™ Microstent
22 / 04 / 2015
Sunshine Heart Receives FDA Approval for Interim Analysis of U.S. Pivotal Trial of C-Pulse(R) Heart Assist System
02 / 03 / 2015
Viveve Announces Distribution Partnership With CoachHouse Medical in the United Kingdom
02 / 03 / 2015
Sunshine Heart Inc. Secures Up to $10 Million in Growth Capital From Silicon Valley Bank
23 / 02 / 2015
Sunshine Heart's German Erlangen Site Achieves First Implant for OPTIONS HF EU Post-Market Study
20 / 01 / 2015
Celladon announces Letter agreement with Novasep, Inc. for potential manufacture of MYDICAR
20 / 01 / 2015
Lonza and Celladon Corporation Establish a Strategic Commercial Manufacturing Collaboration
05 / 11 / 2014
Celladon Corporation Announces Publication of Data
27 / 10 / 2014
New Gene Therapy Approach Shown To Reverse Heart Damage and Improve Long Term Cardiac Function Following Myocardial Infarction in Animal Models.
Ivantis Announces HYDRUS II Glaucoma Study Met Primary Endpoint In a Randomized Controlled Trial
24 / 10 / 2014
Results from Landmark International Study Show Hydrus™ Microstent Significantly Reduced Intraocular Pressure and Medication Use in Patients with Glaucoma Undergoing Cataract Surgery
Displaying records 151-175 of 702